Stock listing
NASDAQ:TCRR Tcr2 Therapeutics Inc Stock
Follow Tcr2 Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TCRR
$1.48 USD
Close on Jun 1, 2023 · No longer trades
- Lowest – highest close
- $0.83 – $34.07 USDSince Feb 14, 2019 · lowest Dec 22, 2022 · highest Jan 12, 2021
Delisted NASDAQ:TCRR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TCRR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Tcr2 Therapeutics Inc on 6ix
- Decks
- 6 decks · latest Mar 6, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2023) | Merger or acquisition | 36 slides | Mar 6, 2023 |
| Technical Presentation (September 2022) | Technical | 34 slides | Sep 28, 2022 |
| Investor Day (October 2021) | Investor day | 65 slides | Oct 20, 2021 |
| Technical Presentation (September 2021) | Technical | 20 slides | Sep 17, 2021 |
| Corporate Update (December 2020) | Corporate update | 21 slides | Dec 14, 2020 |
| Technical Presentation (July 2020) | Technical | 27 slides | Jul 27, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen Webster Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past) | Director · Apr 30, 2020 – Jun 1, 2023 · Past |
| Garry E. Menzel Other companies: Adaptimmune Therapeutics PLC (Non-Executive Director · Since at least Jun 1, 2023); Stoke Therapeutics, Inc. (Director · Since at least Aug 13, 2020); Black Diamond Therapeutics, Inc. (Operating Partner, GHO Capital Partners LLP · Since at least Jan 29, 2020); DaVita Inc. (Senior Vice President, Finance · Sep 9, 2013 – Sep 9, 2013 · Past); Regulus Therapeutics Inc (COO & Executive VP, Finance · Oct 4, 2012 – Dec 11, 2012 · Past) | President and CEO, Director · Feb 13, 2019 – Jun 1, 2023 · Past |
| Mitchell H Finer Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past) | Director · Feb 13, 2019 – Feb 13, 2019 · Past |
| Shawn Tomasello Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past) | Director · Feb 3, 2021 – Jun 1, 2023 · Past |
| Neil Gibson Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past) | Director · Feb 13, 2019 – Jun 1, 2023 · Past |
| Morana Jovan-Embiricos Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Jul 29, 2020); Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Sep 16, 2021 · Past) | Director · Feb 13, 2019 – Feb 19, 2019 · Past |
| Mayur Ian Somaiya Other companies: NewAmsterdam Pharma Company N.V. (Chief Financial Officer · Since at least Dec 29, 2023) | Chief Financial Officer · Feb 13, 2019 – Dec 14, 2020 · Past |
| Robert Hofmeister Other companies: Alaunos Therapeutics, Inc. (Director · Mar 30, 2023 – Jun 6, 2024 · Past) | Chief Scientific Officer · Oct 29, 2020 – Dec 9, 2021 · Past |
| Rosemary Harrison Other companies: Trillium Therapeutics Inc (See Remarks · Jan 1, 2021 – Nov 17, 2021 · Past) | Chief Business & Strategy · Jan 10, 2022 – Jun 1, 2023 · Past |
| Axel Hoos | Director · Apr 13, 2020 – Jun 1, 2023 · Past |
Log in to ask 6ix AI your own questions about Tcr2 Therapeutics Inc.